CLINICAL EVALUATION OF NEBULISED BUDESONIDE IN ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE– A RANDOMISED STUDY
Journal Title: Journal of Evolution of Medical and Dental Sciences - Year 2017, Vol 6, Issue 92
Abstract
BACKGROUND Exacerbations in chronic obstructive pulmonary disease is common and frequent in nature. The present study was done to evaluate the clinical efficacy of nebulised budesonide over parenteral/oral steroids in patients with acute exacerbations of COPD. MATERIALS AND METHODS A randomised controlled study was conducted in a tertiary care teaching hospital. A total of 125 patients with acute exacerbations due to COPD were included in the study. The patients were randomised into study and control groups. The study group patients received inhaled budesonide along with the standard treatment for 5 days, while the control group received standard treatment for acute exacerbation of COPD. The primary outcome variables studied for the treatment efficacy were change in post bronchodilator FEV1, FVC, FEV1/FVC, PEFR. Secondary end points included the changes in dyspnoea score (MMRC grade, SPO2 and SGRQ score). RESULTS A total of 125 patients were finally assessed. Sixty five patients belonged to study group and 60 in the control group. Baseline characteristics were similar and well matched in both the groups. Mean age was 64.20 ± 9.11 years while in control group it was 62.40 ± 11.31 years. There were no improvements in the lung functions (FEV1, FVC, FEV1/FVC, PEFR) at the end of 5 days of nebulised budesonide as compared to the standard therapy. As far as secondary outcome is concerned, it was observed that patients in study group showed better improvement in health related quality of life (HRQL) score as compared to control group at day 5 (p<0.01). Duration of hospitalisation also was lesser in the study group as compared to the control group. No serious adverse effects were observed during the course of the study. CONCLUSION Overall with the nebulised budesonide for the AECOPD, there was not much improvement in the lung functions, but there was improvement in the quality of life and the duration of hospitalisation in the study group. These findings should be confirmed by conducting a larger population based clinical study
Authors and Affiliations
Gajanan S. Gaude, Santosh Nemagouda
Keywords
Related Articles
- EP ID EP279207
- DOI 10.14260/jemds/2017/1422
- Views 71
- Downloads 0
ENDEMIC OF RHINOSPORIDIOSIS: A CLINICOPATHOLOGICAL PROFILE OF 38 CASES IN A SMALL VILLAGE
Rhinosporidiosis is endemic in various parts of India and Srilanka. We report a total of 38 cases in a single locality from Pavagada situated in northeastern part of Karnataka in South India. All patients presen...
AGE ESTIMATION BY CORRELATION OF PHYSICAL AND DENTAL WITH RADIOLOGICAL FINDINGS
BACKGROUND Age estimation is of paramount importance and requires special attention in medico-legal cases. In developing countries like India, because of illiteracy and ignorance regarding the importance of official reco...
ROLE OF FUNDUS FLUORESCEIN ANGIOGRAPHY IN EVALUATION OF RETINAL DISORDERS
BACKGROUND Retinal disorders are the leading cause of legal blindness in the age group of 20 to 65 years. Approximately 18 million people in India have severely impaired vision due to retinal diseases. It has been nearly...
THE STUDY OF CLINICAL FEATURES OF ORGANOPHOSPHORUS POISONING IN INDIAN SOCIETY
RESEARCH QUESTION What are the clinical features of organophosphorus poisoning? DESIGN Prospective study; Interview technique. SAMPLE SIZE A total of 41 cases of OP poisoning were studied. Muscarinic, Nicotini...
EVALUATION OF COLPOSCOPY USING SWEDE SCORE IN SCREENING OF CERVICAL CANCER
BACKGROUND Cervical cancer is a global health problem. It ranks as the 4th leading cause of female cancer in the World,(1) the 2nd leading cause of female cancer in India and the 2nd most common female cancer in the wome...